Emerging frontiers and challenges of artificial intelligence in PSMA-PET imaging: pioneering a new chapter in prostate cancer care.
Prostate-specific membrane antigen positron emission tomography (PSMA-PET) has become pivotal in prostate cancer (PCa) management, offering superior sensitivity over conventional imaging for detecting tumors, metastases, and biochemical recurrence. However, interpretive subjectivity, workflow inefficiencies, and heterogeneous PSMA expression remain significant limitations.
Prostate-specific membrane antigen positron emission tomography (PSMA-PET) has become pivotal in prostate cancer (PCa) management, offering superior sensitivity over conventional imaging for detecting tumors, metastases, and biochemical recurrence. However, interpretive subjectivity, workflow inefficiencies, and heterogeneous PSMA expression remain significant limitations.
What the study was
- Study design
- Review
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Jpn J Radiol
Why it surfaced
Matched watchlist topic 'AI/ML in clinical diagnostics and imaging'. Study design: Review. Score: 8/10 (N:2, R:3, D:1, P:2).
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.